Hua Medicine

• NCT03790839

  Phase 1, Completed, 15 people, 2 Jan 2019

• NCT03790787

  Phase 1, Completed, 16 people, 2 Jan 2019

• NCT02597400

  Phase 1, Completed, 12 people, 5 Nov 2015

• Acquisition

  18 Nov 2022

• Bayer

  Collaboration, 17 Aug 2020

• IPO filing

  31 Aug 2018

Sources: www1.hkexnews.hk

• Efficacy and safety of once-weekly semaglutide 2·4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trial

  Grants or research support, 10 Aug 2026

• Multifactorial chronic kidney disease and the kidney capacity-workload balance

  Consulting or advice, Fees or honoraria, Grants or research support, 5 Jan 2026

Sources: pubmed.ncbi.nlm.nih.gov